Physician profile
John W Scott
NPI 1881600237
$1,320.45
in general payments reported to CMS, 2019-2025
25 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $144 · 2022: $13.88 · 2023: $288 · 2024: $215 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $269.98 | 2019-2025 | |
| Astellas Pharma US INC | $206.44 | 2019-2023 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $148.43 | 2019-2024 | |
| Intuitive Surgical, INC. | $97.76 | 2023 | Da Vinci Surgical System |
| Amgen INC. | $83.84 | 2019 | |
| Calyxo, INC. | $69.49 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $68.95 | 2019-2025 | |
| Blue Earth Diagnostics | $48.09 | 2019 | |
| Janssen Biotech, INC. | $38.26 | 2019-2024 | Erleada, Akeega |
| Boston Scientific Corporation | $35.54 | 2019 | |
| Abbott Laboratories | $28.28 | 2024 | Proclaim |
| Sun Pharmaceutical Industries INC. | $22.11 | 2023 | Yonsa |
| Tempus Ai, INC | $22.04 | 2024 | |
| Progenics Pharmaceuticals, INC. | $21.16 | 2023 | Pylarify |
| Conmed Corporation | $18.07 | 2024 | Airseal |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cycle Pharmaceuticals INC | $17.46 | 2025 | Venxxiva |
| Myriad Genetic Laboratories, INC. | $16.93 | 2025 | Prolaris |
| Bioprotect Medical, INC. | $16.09 | 2025 | Bioprotect Balloon Implant System |
| Davol INC. | $14.59 | 2020 | |
| Alexion Pharmaceuticals, INC. | $13.87 | 2019 | |
| Endo Pharmaceuticals INC. | $13.30 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.25 | 2019 | |
| Dendreon Pharmaceuticals LLC | $12.84 | 2020 | |
| Merck Sharp & Dohme LLC | $12.30 | 2019 | |
| Allergan, INC. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.